Get the Stockscreener App
4.105
10.95%
-0.505
Aquestive Therapeutics Inc Stock (AQST) Forecast
The Aquestive Therapeutics Inc (AQST) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.0183, representing a +46.61% increase from the current price of $4.105. The highest analyst price target is $6.6934, and the lowest is $5.3431.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AQST Price Target
Average 3.8036
(-7.34% Downside)
Is Aquestive Therapeutics Inc (AQST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.56 | Neutral |
| STOCH(9,6) | 50.54 | Neutral |
| STOCHRSI(14) | 41.40 | Neutral |
| MACD(12,26) | -0.0655 | Sell |
| ADX(14) | 16.42 | Neutral |
| William %R | -88.32 | Buy |
| CCI(14) | -176.84 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.6085
Sell
|
4.5771
Sell
|
| MA20 |
4.6558
Sell
|
4.6477
Sell
|
| MA50 |
4.7186
Sell
|
4.6236
Sell
|
| MA100 |
4.4082
Sell
|
4.5151
Sell
|
| MA200 |
4.2809
Sell
|
4.5079
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, AQST could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AQST, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.56 indicates that AQST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.54 indicates that AQST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.4 indicates that AQST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.42 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -176.84 indicates that AQST is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term AQST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aquestive Therapeutics Inc financial reports and earnings history, Aquestive Therapeutics Inc (AQST) stock could reach $5.2845 by 2030, $3.059 by 2040 and $3.5099 by 2050. See the projected annual prices until 2050 of the Aquestive Therapeutics Inc stock below:
- Aquestive Therapeutics Inc (AQST) is expected to reach an average price of $3.3545 in 2035, with a high prediction of $3.5545 and a low estimate of $2.9241. This indicates an $-18.28% rise from the last recorded price of $4.105.
- Aquestive Therapeutics Inc (AQST) stock is projected to chart a bullish course in 2040, with an average price target of $2.4798, representing an $-39.59% surge from its current level. The forecast ranges from a conservative $2.2292 to a sky-high $3.059.
- Our analysts predict Aquestive Therapeutics Inc (AQST) to jump -48.95% by 2045, soaring from $2.0698 to an average price of $2.0956, potentially reaching $2.1895. While $2.0698 is the low estimate, the potential upside is significant.
- Aquestive Therapeutics Inc (AQST) stock is expected to climb by 2050, reaching an average of $2.5068, a $-38.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.5099 and $2.4344, respectively, highlighting the market's uncertainty.
Aquestive Therapeutics Inc Stock (AQST) Year by Year Forecast
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2026
The predicted value for Aquestive Therapeutics Inc (AQST) in 2026 is set at an average of $4.8117. Estimates vary from a peak of $6.6934 to a trough of $2.93, indicating an +17.22% surge from the present price of $4.105.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $6.1934 | $5.3431 | $6.6934 | +50.87% |
| December, 2026 | $4.3237 | $4.1237 | $6.5437 | +5.33% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aquestive Therapeutics Inc (AQST) is $2.7488, with a high forecast of $4.5838 and a low forecast of $0.9138. This indicates an -33.04% decrease from the last price of $4.105.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.2439 | $3.1889 | $4.5838 | -20.98% |
| February, 2027 | $2.8242 | $2.774 | $3.3135 | -31.20% |
| March, 2027 | $2.8646 | $2.3144 | $3.4845 | -30.22% |
| April, 2027 | $2.8648 | $2.6246 | $3.2446 | -30.21% |
| May, 2027 | $1.5052 | $1.4652 | $2.9549 | -63.33% |
| June, 2027 | $1.2894 | $1.253 | $1.6353 | -68.59% |
| July, 2027 | $1.0357 | $0.9457 | $1.3255 | -74.77% |
| August, 2027 | $1.2065 | $0.9138 | $1.326 | -70.61% |
| September, 2027 | $1.7263 | $1.0961 | $2.0762 | -57.95% |
| October, 2027 | $1.7566 | $1.4464 | $1.9562 | -57.21% |
| November, 2027 | $1.2369 | $1.177 | $1.7966 | -69.87% |
| December, 2027 | $1.1722 | $1.1172 | $1.277 | -71.45% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2028
In 2028, Aquestive Therapeutics Inc (AQST) is projected to reach an average price of $2.004, with a high projection of $2.9893 and a low estimate of $1.0187. This indicates an -51.18% fall from the last price of $4.105.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2488 | $1.1773 | $1.4273 | -69.58% |
| February, 2028 | $1.1999 | $1.0584 | $1.2676 | -70.77% |
| March, 2028 | $1.1847 | $1.1129 | $1.3289 | -71.14% |
| April, 2028 | $1.1122 | $1.0373 | $1.2081 | -72.91% |
| May, 2028 | $1.0766 | $1.0187 | $1.2136 | -73.77% |
| June, 2028 | $1.5689 | $1.0687 | $1.5789 | -61.78% |
| July, 2028 | $2.4693 | $1.4491 | $2.9492 | -39.85% |
| August, 2028 | $2.4095 | $2.2894 | $2.9893 | -41.30% |
| September, 2028 | $1.9598 | $1.6297 | $2.6396 | -52.26% |
| October, 2028 | $2.3901 | $1.8299 | $2.5901 | -41.77% |
| November, 2028 | $1.9404 | $1.9303 | $2.4702 | -52.73% |
| December, 2028 | $1.8807 | $1.7706 | $2.0834 | -54.19% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2029
The 2029 price forecast for Aquestive Therapeutics Inc Stock (AQST) is $4.0425 on average, with a high prediction of $6.5327 and a low estimate of $1.5522. This represents an -1.52% decrease from the previous price of $4.105.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.721 | $1.5522 | $2.121 | -58.07% |
| February, 2029 | $2.0313 | $1.7064 | $2.1213 | -50.52% |
| March, 2029 | $2.4016 | $2.0314 | $2.9716 | -41.50% |
| April, 2029 | $2.9319 | $2.1417 | $3.1119 | -28.58% |
| May, 2029 | $2.9322 | $2.622 | $3.112 | -28.57% |
| June, 2029 | $3.9724 | $2.7524 | $4.2524 | -3.23% |
| July, 2029 | $4.5628 | $3.9026 | $6.5327 | +11.15% |
| August, 2029 | $4.373 | $4.023 | $4.843 | +6.53% |
| September, 2029 | $3.4133 | $3.2132 | $4.2529 | -16.85% |
| October, 2029 | $2.8637 | $2.7537 | $3.5734 | -30.24% |
| November, 2029 | $3.5039 | $2.5437 | $3.6039 | -14.64% |
| December, 2029 | $4.5443 | $3.2644 | $4.6193 | +10.70% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2030
Aquestive Therapeutics Inc Stock (AQST) is expected to reach an average price of $4.2661 in 2030, with a high forecast of $6.1051 and a low forecast of $2.4272. This signifies an +3.93% surge from the last price of $4.105.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1445 | $4.3343 | $5.2845 | +25.32% |
| February, 2030 | $5.2548 | $4.8399 | $5.5946 | +28.01% |
| March, 2030 | $5.7951 | $4.8779 | $6.1051 | +41.17% |
| April, 2030 | $5.3954 | $4.6653 | $5.9701 | +31.43% |
| May, 2030 | $3.8257 | $3.6856 | $5.5905 | -6.80% |
| June, 2030 | $3.4059 | $3.2659 | $4.0958 | -17.03% |
| July, 2030 | $3.3163 | $3.1761 | $3.9362 | -19.21% |
| August, 2030 | $3.5165 | $2.7564 | $3.5515 | -14.33% |
| September, 2030 | $2.8169 | $2.5068 | $3.6966 | -31.38% |
| October, 2030 | $3.0972 | $2.772 | $3.3561 | -24.55% |
| November, 2030 | $3.8674 | $2.4272 | $4.1224 | -5.79% |
| December, 2030 | $4.0278 | $3.4376 | $4.0975 | -1.88% |
0.70%
5.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):